ERBB2 and plasma cell myeloma: For example, DNA aptamers targeting nucleolin, PDGF, and HER2 and RNA aptamers targeting VEGF, HER3, and EGFR have been explored.16 In myeloma, two aptamers have been developed as antagonists to inhibit the interaction between protein with its ligand.